What is Gliclazide?
Category: Prescription Drugs
Most popular types: Diamicron Gliclazide MR Apo-Gliclazide Show all
Gliclazide is a sulfonylurea antidiabetic agent used for the management of type 2 diabetes mellitus (noninsulin dependent).
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Diabetes type 2 | 105 | 43 | |
| Elevated blood sugar (hyperglycemia) | 5 | 6 | |
| Increase effect of another treatment | 2 | 0 | |
| Maturity-onset diabetes in young | 2 | 0 | |
| Attention deficit/hyperactivity disorder | 1 | 0 | |
| Diabetes type 1 | 1 | 1 |
- Major
- Moderate
- Slight
- None
- Can't tell
Side effects
Side effects as an overall problem
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 1 | |
| Moderate | 3 | |
| Mild | 9 | |
| None | 37 |
Commonly reported side effects and conditions associated with Gliclazide
| Side effect | Patients | Percentage |
|---|---|---|
| Low blood sugar (hypoglycemia) | 6 | |
| Diarrhea | 2 | |
| Lightheadedness | 2 | |
| Heartburn | 1 | |
| Lethargy | 1 | |
| Migraine headaches | 1 |
Duration
Stopped taking Gliclazide
| Duration | Patients | Percentage |
|---|---|---|
| Less than 1 month | 2 | |
| 1 - 6 months | 2 | |
| 6 months - 1 year | 1 | |
| 1 - 2 years | 4 | |
| 2 - 5 years | 6 | |
| 5 - 10 years | 2 | |
| 10 years or more | 1 |
What people switch to and from
Patients started taking Gliclazide after stopping:
| Treatment | Patients | Percentage |
|---|---|---|
| Metformin (Metformin ER) | 3 | |
| Dapagliflozin (Farxiga) | 1 | |
| Glyburide (Euglukon) | 1 | |
| Liraglutide (Victoza) | 1 | |
| Sitagliptin (Januvia) | 1 |
Patients stopped taking Gliclazide and switched to:
| Treatment | Patients | Percentage |
|---|---|---|
| Metformin (Metformin ER) | 5 | |
| Dapagliflozin (Farxiga) | 2 | |
| Insulin NPH (Novolin N) | 2 | |
| Empagliflozin-linagliptin (Glyxambi) | 1 | |
| Glyburide (Euglukon) | 1 |
Last updated: